Back

Discussion.

26 August 2022 (13:35 - 13:45)
Organised by:
Congress Presentation Part of: A decade of innovation, guidelines and paradigm shifts in LDL-C management (10th annual symposium) Lipid-Lowering Agents Open Access ESC Congress 2022

About the speaker

Photo
Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Introduction: changing paradigms in LDL-c reduction.
Professor K. Ray (London, GB)
Slides Video
Presentation thumbnail
LDC-c: new insights into its role as causal risk factor and target for therapy
Professor B. Ference (Cambridge, GB)
Slides Video
Presentation thumbnail
Targeting the PCSK9 pathway: where do novel therapies fit in?
Associate Professor A. Navar (Dallas, US)
Slides Video
Presentation thumbnail
Addressing the unmet needs in LDL-c lowering: what can we expect?
Professor J. Kastelein (Amsterdam, NL)
Slides Video

Access the full session

Session thumbnail
A decade of innovation, guidelines and paradigm shifts in LDL-C management (10th annual symposium)
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 13:35 CET
You may be interested in
thumbnail
Congress Session
The LDL-c challenge in patients with high cardiovascular risk: integrating innovative therapies in clinical management
25 August 2023
thumbnail
Congress Session
Ask the Trialists - VICTORION
30 August 2025
thumbnail
Congress Session
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias: Ask the Task Force
31 August 2025
thumbnail
Congress Presentation
Panel discussion
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources